The CDC said on Friday said it should resume use of Johnson & Johnson's COVID-19 vaccine, despite a very rare risk of blood clots.
LISA HUGHES: The CDC just decided to recommend the use again of the Johnson & Johnson vaccine. Its advisory panel had been meeting all day. The decision came just moments ago after the agency discussed some new confirmed cases of blood clots. The number of cases, though, is still very small, particularly given the nearly 7 million doses already administered in the United States. Thanks for joining us. I'm Lisa Hughes.
DAVID WADE: And I'm David Wade. This is obviously a very big decision. WBZ's Paula Ebben has been monitoring that meeting and is here now with the latest, Paula.
PAULA EBBEN: Well, David and Lisa, today's meeting of the Centers for Disease Control and Prevention's Advisory committee was meant to reconsider whether to lift the pause on the Johnson & Johnson vaccine. And the panel has decided, as Lisa just mentioned, to allow the Johnson & Johnson COVID-19 shot to be distributed once again.
Now the CDC had placed a pause on the one-shot vaccine 10 days ago after several women who had received it developed a rare form of blood clots. Today, the agency reported that there have been 15 reported cases of blood clots. And now three deaths have been possibly linked to the J&J vaccine. There have been nearly 7 million doses of the one-shot vaccine given.
The CDC will add a warning label to the vaccine so that once, again, people can be warned about the blood clot risk. So again, breaking news just moments ago. The CDC is lifting the pause on the Johnson & Johnson vaccine. The White House says 9 million J&J COVID-19 vaccines, David, are ready to go.